UK’s first investment fund dedicated to psychedelic healthcare
Marijuana Stocks, Finance, & InvestingUncategorized December 19, 2020 MJ Shareholders
In a first for the UK, an investment fund dedicated to psychedelic healthcare has been launched.
The new fund comes as recent rigorous clinical trials have demonstrated psychedelics’ potential to treat unmet needs in mental illnesses, including post-traumatic stress disorder (PTSD), depression, addiction, and anxiety.
It has been launched by London-based Venture Capital Neo Kuma Ventures which has already attracted millions of pounds in investment, has no set cap and will continue to draw venture capital through the first half of 2021.
Read More
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers
